Our results of three NSCLC cells lines suggested that miR-488 increased cell resistance to cisplatin in a mild way, which may be partly due to the increased expression of XPC and RPA14 of the NER pathway when eIF3a is down regulated by miRNA-488. The gene discussed is RPA3; the disease is non-small cell lung carcinoma.